Image

A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer

Investigational Noninvasive Screening for Gastrointestinal Cancer Using miRNA Signature

Recruiting
18 years and older
All
Phase N/A
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates gastrointestinal cancer. It focuses on developing a noninvasive method to identify this condition using circulating microRNAs (miRNAs).

The study evaluates the effectiveness of a miRNA-based signature to distinguish between cancer and non-cancer individuals. The purpose of this study is to create a reliable and accessible screening tool for early detection of gastrointestinal cancer.

  • Who can participate: Adults aged 18 and older who have been diagnosed with certain gastrointestinal cancers or are non-cancer controls can participate. Participants must have available retrospective blood samples and agree to the use of de-identified data.
  • Study details: Participants will provide blood samples for analysis. The study involves comparing these samples to identify specific miRNAs associated with cancer.
Print
Study details
    Hepatocellular Carcinoma (HCC)
    Cholangiocarcinoma
    Pancreatic Ductal Adenocarcinoma (PDAC)
    Esophageal Squamous Cell Carcinoma (ESCC)
    Gastric Cancer (GC)
    Colorectal Cancer Screening

NCT07224750

City of Hope Medical Center

31 July 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.